A novel sacral neuromodulation protocol is associated with reduction in removal for device infection.
Colin GoudelockeHayden HillNicholas MajorAnastasia CouvarasAmy LongPublished in: International urogynecology journal (2023)
The study was initiated prior to January 18, 2017 and does not meet the definition of an applicable clinical trial (ACT) as defined in section 402 (J) of the US PHS Act.